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background: If channels are functionally expressed in atrioventricular (AV) nodal tissue. Whether the prototypical If inhibitor, ivabradine (IVA), at 
clinically proven safe levels can slow AV node conduction to reduce ventricular rate (VR) during AF (atrial fibrillation) is unknown.
methods: Effects of IVA (0.1 mg/kg, i.v., bolus) were studied in an anesthetized pig (N=7) model of AF induced by intrapericardial acetylcholine 
and burst pacing.
results: IVA increased atrial-His (A-H) interval from 96±9 (control, CTRL) to 106±10 msec at 130 beats/min and from 100±9 (CTRL) to 117±8 
msec at 180 beats/min (both p<0.02) (Fig.). The A-H interval increase was greater at the higher heart rate (p<0.02). IVA reduced VR during AF from 
240±21 to 211±25 bpm (p<0.05) (Example, Fig.). The IVA-induced increase in A-H interval was correlated with VR (r=-0.85, p=0.03, at 130 beats/
min; r=-0.95, p=0.003, at 180 beats/min). AF dominant frequency (8.5±0.9 to 8.7±1.1 Hz, NS) at 6 min and left ventricular (LV) dP/dt (1672±222 
to 1889±229 mmHg/sec, NS) at 60 min after AF induction were unaffected.
conclusion: IVA caused a use-dependent increase in A-H interval that was highly correlated with VR during AF. AV node conduction slowing during 
high nodal activation rates associated with AF is a mechanism of IVA-induced VR decrease. Absence of depression in contractility constitutes an 
advantage over agents that act on L-type calcium channels. Thus, If inhibition in the AV node may provide a promising target to reduce VR during AF.
 
